Amyloid beta peptide processing, insulin degrading enzyme, and butyrylcholinesterase

Neurochemical Research

Volumn 26, Issue 4, 2001, Pages 453-456

  Balasubramanian, A S ^a  

^a BHARATHIAR UNIVERSITY   (India)

Author keywords

Alzheimers disease; Amyloid peptide; Butyrylcholinesterase; Insulin degrading enzyme

Indexed keywords

ACRYLAMIDE; AMYLOID BETA PROTEIN; CHOLINESTERASE; INSULINASE; MUTANT PROTEIN;

ALZHEIMER DISEASE; CELLULAR DISTRIBUTION; GLIA; HUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN LOCALIZATION; PROTEIN PROCESSING; REVIEW;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; ANIMALS; BUTYRYLCHOLINESTERASE; INSULYSIN; MICE;

EID: 0034933147     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1010967602362     Document Type: Review

References (28)

1. Role of the beta amyloid precursor protein in Alzheimers disease
2. Alzheimers disease; An imbalance of proteolytic regulation?
3. The role of presenilins in Alzheimers disease. Modulation of amyloid beta protein precursor processing as a means of retarding progression of Alzheimers disease
4. Alzheimers disease: Genotypes, phenotype and treatments
5. Processing of beta amyloid precursor protein and its regulation in Alzheimers disease
6. Tacrine: A pharmacological review
7. Cerebrospinal fluid acetylcholinesterase activity in senile dementia of the Alzheimer type
8. Cerebrospinal fluid cholinesterases in aging and dementia of the Alzheimer type
9. Protease inhibitors and indoleamines selectivity inhibit cholinesterases in the histopathological structures of Alzheimers disease
10. Special properties of cholinesterases in the cerebral cortex of Alzheimers disease
11. The identity of the serotonin sensitive aryl acylamidase with acetylcholinesterase from human erythrocytes, sheep basal ganglia and electric eel
12. The peptidase activity of human serum butyrylcholinesterase. Studies using monoclonal antibodies and characterisation of the peptidase
13. Non-cholinergic functions of cholinesterases
14. Evidence for a zinc binding site in human serum butyrylcholinesterase
15. Metal binding motifs in cholinesterases and neuroligins-structural comparison
16. Cholinesterases and the pathology of Alzheimers disease
17. Neuroglial cholinesterases in the normal brain and in Alzheimers disease: Relationship to plaques, tangles and patterns of selective vulnerability
18. Anomalous acetylcholinesterase in the lumbar cerebrospinal fluid in Alzheimers disease
19. Identification of human plasma cholinesterase variants using molecular biological techniques
20. Synergy between the genes for BChE-K variant and apolipoprotein E4 in late-onset confirmed Alzheimers disease
21. Analysis of association between Alzheimers disease and the K-variant of butyrylcholinesterase
22. Butyrylcholinesterase K variant is genetically associated with late onset Alzheimers disease in Northern Ireland
23. Association of BChE-K variant with cholinesterase positive neuritic plaques in the temporal cortex in late-onset Alzheimers disease
24. Insulin-degrading enzyme regulates extracellular levels of amyloid beta protein by degradation
25. Neurons regulate extracellular levels of amyloid beta protein via proteolysis by insulin degrading enzyme
26. Butyrylcholinesterase in the life cycle of amyloid plaques
27. Amyloidogenic determinant as a substrate recognition motif of insulin-degrading enzyme
28. The secretion of amyloid beta peptides is inhibited in the tacrine treated human neuroblastoma cells